All times listed are Pacific Standard Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.
- Home
-
Sunday, Nov 12th
4:00 PM – 5:00 PM PT12S153: Bad to the Bone: Osteoclasts in Metabolic Bone DiseaseLocation: Room 24A-C
Moderator: – University of Oklahoma Health Sciences Center
Moderator: – Duke University
-
Sunday, Nov 12th
4:00 PM – 4:15 PM PTPaget's Disease of Bone: An Ancient Disease with Modern Genetic FindingsLocation: Room 24A-C
Speaker: – University of Edinburgh
-
Sunday, Nov 12th
4:15 PM – 4:30 PM PTThe Molecular Effects of Hematopoiesis on Osteoclastogenesis and OsteoporosisLocation: Room 24A-C
Speaker: – Hospital for Special Surgery
-
Sunday, Nov 12th
4:30 PM – 4:45 PM PTNew Insights into Osteoclast BiologyLocation: Room 24A-C
Speaker: – GARVAN INSTITUTE
-
Sunday, Nov 12th
4:45 PM – 5:00 PM PT -
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT(1996–2018) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science PosterLocation: Poster Hall
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1996: Variation in Dual-energy X-ray Absorptiometry Reporting: A National Survey of Veterans Health Administration ClinicsLocation: Poster Hall
Abstract Poster Presenter: – University of Utah School of Medicine
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1997: A Randomized, Double-blind, Phase III Study to Compare SB16 (Proposed Denosumab Biosimilar) to Reference Denosumab in Patients with Postmenopausal OsteoporosisLocation: Poster Hall
Abstract Poster Presenter: – Aarhus University Hospital
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1998: How to Tailor Osteoporosis Therapies in Patients with Advanced Liver Disease? Variations of Renal Function by Creatinine and Cystatin CLocation: Poster Hall
Abstract Poster Presenter: – General University Hospital Dr. Balmis-ISABIAL
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1999: One-year Incidence of Clinical Fragility Fractures After Implementing an Osteoporosis Care Protocol in Patients Eligible for Liver TransplantationLocation: Poster Hall
Abstract Poster Presenter: – General University Hospital Dr. Balmis-ISABIAL
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2000: Efficacy of Romosozumab for Glucocorticoid-induced Osteoporosis in Patients with Rheumatic Diseases; A Prospective StudyLocation: Poster Hall
Abstract Poster Presenter: – Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2001: Burden of Metabolic Bone Disease in Patients with IgG4-Related Disease with and Without Autoimmune PancreatitisLocation: Poster Hall
Abstract Poster Presenter: – Massachusetts General Hospital
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2002: Cost-Effectiveness Analysis of Sequential Treatment with Abaloparatide Followed by Alendronate in US Women and Men with Multiple Previous FracturesLocation: Poster Hall
Abstract Poster Presenter: – self
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2003: Effects of Abaloparatide on Cortical and Trabecular Compartments by 3D-DXA in Men with OsteoporosisLocation: Poster Hall
Abstract Poster Presenter: – Massachusetts General Hospital
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2004: Bone Health Following Bariatric Surgery: A Single Center Quality Improvement StudyLocation: Poster Hall
Abstract Poster Presenter: – Rush University
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2005: Secondary Prevention of Osteoporosis in Hip Fracture Care for Elderly Patients. Clinical and Functional Profile of UsersLocation: Poster Hall
Abstract Poster Presenter: – University Healthcare Complex of Salamanca
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2006: Improvement of Care: Osteoporosis Screening in a Resident-led Primary Care ClinicLocation: Poster Hall
Abstract Poster Presenter: – Unity Hospital, Rochester Regional Health
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2007: Effects of IL-17 Blockade on Skeletal Microarchitecture in Patients with Axial Spondyloarthritis: An HR-pQCT StudyLocation: Poster Hall
Abstract Poster Presenter: – Columbia Vagelos College of Physicians and Surgeons
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2008: Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the U.S. Medicare ProgramLocation: Poster Hall
Abstract Poster Presenter: – University of Alabama at Birmingham
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2009: Screening and Treatment of Low Bone Mineral Density in Allogeneic Hematopoietic Cell Transplant PatientsLocation: Poster Hall
Abstract Poster Presenter: – Denver Arthritis Clinic
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2010: B-FROST: Chronic OBstructive Pulmonary Disease and Vertebral FRacture of OSTeoporotic Origin: Results of a Real-life CohortLocation: Poster Hall
Abstract Poster Presenter: – Armentières Hospital Center
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2011: Predicting Fractures in Patients with Isolated Lumbar Spine Osteoporosis Compared to Those with Isolated Hip OsteoporosisLocation: Poster Hall
Abstract Poster Presenter: – Rheumatology (Oxford)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2012: Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or DenosumabLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario i Politecnic La Fe (Valencia-Spain)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2013: Clinical Characteristics and Risk Factors Associated with Fragility Fractures in Patients with Primary and Idiopathic Mast Cell Activation SyndromesLocation: Poster Hall
Abstract Poster Presenter: – Hospital General Universitario Gregorio Marañón
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2014: The Role of Orosomucoid 2 in the Regulation of Bone Remodeling by Inhibiting Osteoclastogenesis and Promoting OsteogenesisLocation: Poster Hall
Abstract Poster Presenter: – Wonkwang University Hospital
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2015: Synergistic Effect Between Denosumab and Immune Checkpoint Inhibitors : A Retrospective Study of 268 Patients with Bone MetastasesLocation: Poster Hall
Abstract Poster Presenter: – Hospices civils de lyon
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2016: Generation of a Human 3D in Vitro Bone Model That Mimics Glucocorticoid-induced OsteoporosisLocation: Poster Hall
Abstract Poster Presenter: – Charité University Medicine Berlin
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2017: Lupus Nephritis Is Strongly Associated with Low Bone Mineral Density and Osteoporosis in Patients with Systemic Lupus ErythematosusLocation: Poster Hall
Abstract Poster Presenter: – Charité University Medicine Berlin
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2018: Development of an Osteoporosis Treatment Gap DashboardLocation: Poster Hall
Abstract Poster Presenter: – UMass Chan Medical School
-
Tuesday, Nov 14th
12:00 PM – 12:10 PM PT2429: Romosozumab versus Denosumab in High-risk Patients Treated with Glucocorticoids: Interim 12-month Results from a Pilot Randomized Controlled TrialLocation: Exhibit Hall A-B
Plenary Presenter: – Tuen Mun Hospital
-
Tuesday, Nov 14th
4:00 PM – 5:30 PM PT14T174: Abstracts: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science (2527–2532)Location: Room 11A-B
Abstract Moderator: – University of Utah School of Medicine
Abstract Moderator: – VA PUGET SOUND/UNIVERSITY OF WASHINGTON
-
Tuesday, Nov 14th
4:00 PM – 4:10 PM PT2527: Risk Factors for Bone Loss in Systemic Lupus ErythematosusLocation: Room 11A-B
Presenting Author: – Johns Hopkins University
-
Tuesday, Nov 14th
4:15 PM – 4:25 PM PT2528: Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-Fracture Treatment Among Commercially Insured Postmenopausal Women in the United StatesLocation: Room 11A-B
Presenting Author: – Amgen, Inc.
-
Tuesday, Nov 14th
4:30 PM – 4:40 PM PT2529: Comparative Effectiveness of Denosumab versus Zoledronic Acid Among Postmenopausal Women with Osteoporosis in the U.S. Medicare ProgramLocation: Room 11A-B
Presenting Author: – University of Alabama at Birmingham
-
Tuesday, Nov 14th
4:45 PM – 4:55 PM PT2530: Risk Evaluation of Osteoporotic Fractures Following Lung Transplantation (LT): A Retrospective Cohort Study Conducted at an International Transplant CenterLocation: Room 11A-B
Presenting Author: – Cleveland Clinic Foundation
-
Tuesday, Nov 14th
5:00 PM – 5:10 PM PT2531: Proton Pump Inhibitor Use Is Associated with Impaired Bone Mineral Density but Not Bone Microarchitecture in Patients with Inflammatory Rheumatic and Musculoskeletal Diseases Taking GlucocorticoidsLocation: Room 11A-B
Presenting Author: – Charité - Universitätsmedizin Berlin
-
Tuesday, Nov 14th
5:15 PM – 5:25 PM PT2532: Prevalence and Disease-Specific Factors Associated with Osteoporosis in Systemic Sclerosis: A Cross-Sectional Analysis of Two Large European CohortsLocation: Room 11A-B
Presenting Author: – Charité University Medicine Berlin
